Autonomic
nervous system
Sympathetic or adrenergic
system.
Parasympathetic or cholinergic
system.
The ANS is a two neurone
system. Autonomic nerves start in the CNS and travel to a peripheral ganglion,
a second neurone then travels to the target tissue.
So the order is
preganglionic neurone – synapse in ganglia – postganglionic neurone – synapse –
tissue receptor.
The sympathetic system uses
acetylcholine (Ach) between the first and second neurone and norepinephrine
(noradrenaline) between the second neurone and the tissues.
The parasympathetic system
uses acetylcholine in both synapses.
Alpha
and beta sympathetic adrenergic receptors
Alpha receptors respond to
noradrenaline and beta respond to adrenaline.
Receptors in the sympathetic
nervous system are classified as alpha or beta; these are sub divided into a1
a2 and B1 B2
Alpha1 adrenergic receptors
are found in smooth muscle of peripheral blood vessels and of GI and GU
sphincters.
Stimulation of alpha 1
receptors may causes peripheral vasoconstriction, constriction of nasal vessels
reducing nasal congestion, local injection will cause localised peripheral
vasoconstriction.
Alpha 2 adrenergic receptors
are located on the presynaptic sympathetic neurones to moderate the release of
neurotransmitter between the first and second neurone. Stimulation of alpha 2 receptors reduces the
release of neurotransmitter between the first and second sympathetic neurones.
This reduces the magnitude of the sympathetic effect.
Beta 1 receptors are found
on the myocardium and fatty tissues. Stimulation of beta 1 receptors has a
chronotropic and inotropic effect. Stimulation of beta 1 in fatty tissues
promotes the breakdown of fat to fatty acids which may be used to produce
energy.
Beta 2 receptors are located
in bronchiole smooth muscle and smooth muscle in blood vessels in the skeletal
muscles, heart and brain. Stimulation of beta 2 receptors causes smooth muscle
to relax.
Muscarinic
and nicotinic cholinergic parasympathetic receptors
While the sympathetic nervous
system promotes `fight or flight` the parasympathetic promotes energy uptake
and conservation. It also promotes elimination. The neurotransmitter is Ach.
Two forms of ACh receptor
occur. Muscarinic receptors are found on the postganglionic neurone, i.e.
between the second neurone and the target tissue. They are named because this
subset of ACh receptors are stimulated by muscarine.
Nicotinic ACh receptors are
found at the ganglia of the sympathetic and parasympathetic NS and at
neuromuscular junctions. These receptors may be stimulated by nicotine as well
as Ach.
Drugs
affecting the ANS
Sympathomimetics
Sympathomimetics or
adrenergic drugs stimulate (i.e. mimic) the action of the sympathetic NS. Some
mimic the action of the catacholamines i.e. adrenaline, noradrenaline and
dopamine.
These drugs may stimulate
beta 1 or beta 2 receptors.
Beta 1
stimulation will increase cardiac output and beta 2 stimulation will cause
peripheral vasoconstriction and bronchodilation.
Sympatholytic
Sympatholytic or adrenergic
blocking drugs interfere with the action of the sympathetic NS.
They may block alpha or beta
receptors. Alpha blockers cause vasodilation so are useful to lower BP, treat
Raynaud`s, PVD and migraine.
Beta blockers will lower
heart rate so reduce myocardial oxygen demand. Used to treat high blood
pressure and some cardiac dysrhythmias. May cause bronchoconstriction.
Parasympathomimetic
Parasympathomimetic or
cholinergic drugs stimulate or mimic the activities of the parasympathetic NS
and so mimic the activity of ACh.
These drugs may mimic the
action of ACh or inhibit the activity of acetylcholinesterase.
Pyridostigmine is a
nicotinic agonist and can be used to treat myasthenia gravis. Muscarinic
cholinergics are used in conditions of the eye GU and GI tract.
Parasympatholytic
Parasympatholytic or
anticholinergis drugs interfere with the function of the parasympathetic NS.
Block ACh receptors and may
be specific to muscarinic or nicotinic receptors, or may be non-specific acting
on both.
Scopolamine and atropine are
anticholinergics, they block ACh receptors.
Decrease GI and respiratory
secretions. Cause bronchodilation.
Cause tachycardia in higher
doses. Will dilate the pupil as eye drops.
Work in Parkinson’s
features.
Relax the detrusor and
constrict urinary sphincter so may be used in incontinence and reflex
neurogenic bladder.
Many antispasmodics
antagonise ACh.